National Drug Code (NDC) Database
Takeda Pharmaceutical Company Limited
-
NDC:
11532-3662
-
Nonproprietary Name:
leuprolide acetate
-
Dosage Form:
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
11.25 mg/1.5mL
-
Substance:
LEUPROLIDE ACETATE
-
Start Marketing Date:
1997-03-07
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Takeda Pharmaceutical Company LTD
-
NDC:
11532-5001
-
Nonproprietary Name:
pioglitazone hydrochloride
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
PIOGLITAZONE HYDROCHLORIDE
-
Start Marketing Date:
2011-05-31
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Takeda Pharmaceuticals America, Inc.
-
NDC:
64764-075
-
Nonproprietary Name:
VEDOLIZUMAB
-
Dosage Form:
LIQUID
-
Product Type:
BULK INGREDIENT
-
Strength:
95 mg/95mg
-
Substance:
VEDOLIZUMAB
-
Start Marketing Date:
2024-08-26
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
Takeda Pharmaceuticals Co LTD
-
NDC:
11532-1255
-
Nonproprietary Name:
alogliptin and metformin hydrochloride
-
Dosage Form:
TABLET, FILM COATED
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
12.5; 500 mg/1; mg/1
-
Substance:
ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE
-
Start Marketing Date:
2013-02-05
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
TAPI Croatia Industries Ltd.
-
NDC:
11722-085
-
Nonproprietary Name:
Brexpiprazole
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
BREXPIPRAZOLE
-
Start Marketing Date:
2026-02-25
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
TAPI Czech Industries s.r.o.
-
NDC:
84644-065
-
Nonproprietary Name:
Acoramidis HCl
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
ACORAMIDIS
-
Start Marketing Date:
2026-01-29
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
TAPI Hungary Industries Kft.
-
NDC:
84671-1062
-
Nonproprietary Name:
ORIPAVINE
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
5 kg/5kg
-
Substance:
ORIPAVINE
-
Start Marketing Date:
2026-06-12
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
CII
-
Certified Through:
2027-12-31
TATEYAMA KASEI CO.,LTD.
-
NDC:
53883-5784
-
Nonproprietary Name:
Istradefylline
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
ISTRADEFYLLINE
-
Start Marketing Date:
2021-07-28
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
TAYCA CORPORATION
-
NDC:
61503-323
-
Nonproprietary Name:
ZINC OXIDE
-
Dosage Form:
POWDER
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
9.43 kg/10kg
-
Substance:
ZINC OXIDE
-
Start Marketing Date:
2026-01-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
TCB USA Corporation
-
NDC:
62485-052
-
Nonproprietary Name:
Aspirin
-
Dosage Form:
TABLET, COATED
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
325 mg/1
-
Substance:
ASPIRIN
-
Start Marketing Date:
2023-05-27
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Create a New Buying Request
Fields marked with * are mandatory.